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Introduction
As a result of studies associating rigorous inpatient glycemic control with improved clinical outcomes, clinicians, hospitals, and standards organizations have shown increased interest in the glycemic management of hospitalized patients. [1] [2] [3] [4] [5] [6] Authors publishing on this topic have employed a variety of definitions for glycemic control. To facilitate valid comparisons among studies or institutions, we previously proposed standard definitions for glycemic control, or "glucometrics." 7 We have also noted a gap between the development of new methods or standards and their routine use in clinical settings. The logistics of implementation often slow the adoption of quality improvement initiatives. Information technology can play a key role in overcoming such practical barriers, and in bridging the divide between research and clinical practice. 8 All efforts to measure the quality of medical care face the twin hurdles of collecting and compiling the requisite clinical data, then developing protocols to calculate, report, and compare metrics. For glucometrics, 7 the availability of point-of-care meters capable of storing bedside glucose measurements from many patients eases to some degree the burden of data collection. However, the calculation of glucometrics is not straightforward. To provide useful information, a glucose data set must be partitioned several times, then statistics and event rates must be calculated. The entire process must then be repeated for multiple data sets.
Not all institutions have ready resources to develop algorithms for these complex and laborious analyses. To remove this barrier to assessing the quality of inpatient glycemic control, we built an open access Web application capable of computing glucometrics on uploaded data.
Glucometrics
In outpatients with diabetes, measurement of hemoglobin A1c (HbA1c) is a valid and reliable proxy for glycemic exposure over the previous two to three months. Unfortunately, such a measure is not appropriate for short inpatient stays. Instead, glucometrics analyze a patient's bedside glucose measurements, using three time units relevant to hospitalized patients.
Just as HbA1c is a three-month measure of glycemic control, the mean bedside glucose from a patient's hospital stay is an n-day measure of glycemia. This varies with the patient's length of stay, measured in days. Call this the patient-stay metric. Similarly, the mean of a patient's glucose values for one day is a one-day measure of glycemia. Call this the patient-day metric. A single glucose measurement is a spot measure of glycemia during the few hours between measured samples. Call this the patient-sample metric (Figure 1 ).
Glucometrics are calculated on an inpatient cohort, for example, all patients on a single patient care unit with bedside glucose readings, over a one-month period. The cohort's mean, median, and variability of glucose measurements (whether individual samples or mean values) are then calculated for each of the three metrics discussed earlier.
Additionally, glucometrics calculate the percentage of measurements that fell within a prespecified target glucose range, and the percentage of measurements that met prespecified criteria for adverse events, namely hypoglycemia or marked hyperglycemia. These are the percentages of patient-stays, -days, or -samples that:
fall within a target glucose range, for example, 70-149 mg/dl; or contain hypoglycemic readings (<70 mg/dl); or contain markedly hyperglycemic readings (>299 mg/dl).
The values chosen as endpoints for these ranges are rather arbitrary. Other individuals may differ in their definitions for target levels or adverse metabolic events.
Adverse event rates vary widely, depending on the time unit used for calculation. For any cohort, the number of patient-stays is smallest, the number of patient-days is intermediate, and the number of patient-samples is largest. As an example, two patients hospitalized for five days with four glucose measurements daily, count for two patient-stays, ten patient-days, and forty patientsamples. One episode of hypoglycemia during a patientstay marks that entire stay as "hypoglycemic." This fact, combined with the smallest denominator, patient-stays (n = 2 in the example), yields the highest hypoglycemia rate. Arguably, the patient-stay metric gives an overly pessimistic impression of hypoglycemia rates during that hospitalization. On the other hand, one hypoglycemic sample divided by the largest denominator, patientsamples (n = 40 in the example), yields the lowest hypoglycemia rate. Arguably, this is an overly optimistic impression.
A patient-day is recorded as "hypoglycemic" if any measurement on that day was in the hypoglycemic range. However, the denominator here is patient-days (n = 10 in the example), an intermediate number between patientstays and patient-samples, yielding an intermediate hypoglycemia rate, perhaps most reflective of the quality of care. Note that of the three metrics, only the patientday metric represents a standard, unvarying time interval. Conversely, both the length of patient-stays and the time between patient-samples can vary widely from one cohort to another, making comparisons difficult. For these reasons, we recommend the patient-day metric for measuring adverse metabolic event rates. This metric most accurately reflects the quality of glycemic management.
Glucometrics Calculation
The process of glucometrics calculation begins with the collection of glucose data. While data flow will vary from one institution to another, here is one model: A patient has a bedside glucose measurement, and an individual glucose meter stores this glucose value, the patient's medical record number, and the time of the measurement. After many such measurements on several patients over a week, the meter is docked to a connection module on or near the ward. The meter then uploads a data file into a central hospital workstation. This workstation, which stores all data files sorted by floor and by glucometer, can also export files for analysis. Such files may contain data from a single floor, or may contain aggregate data from many floors.
A data file consists of rows of glucose measurements with many columns or fields for various other attributes, such as meter serial number, location, or operator. The calculation of glucometrics requires only three fields: the patient's unique numerical identifier (e.g., medical record number), the timestamp, and the blood glucose result.
Patient-sample metrics may be calculated using the whole data file. For patient-stay metrics, the file is partitioned into patient subsets using the medical record number. For patient-day metrics, each patient subset is further partitioned into individual calendar days, using the timestamp. Summary statistics and event rates are then calculated for each of these data subsets. For further details on the analysis of glucometrics, please see the Glucometrics™ Web site.
While each institution wishing to monitor its inpatient glycemic management could develop methods for the data manipulation described earlier, the process is laborious. In addition, if subsequent analyses are not fully automated, operator error is likely during the multiple steps involved.
Methods
We developed a database-backed Web application that calculates and reports glucometrics. It is accessible at http://metrics.med.yale.edu. A user logs securely into the system, and then creates an institution name under which to upload anonymized data files. This institution can be further subdivided into wards or patient care units. Upon uploading a data file, the application computes glucometrics, generating a report as a Portable Document Format (PDF) file. The original data file and its PDF report are stored together under the institution and/or ward, and can be accessed at a later time. This feature allows each user to follow a ward's (or hospital's) performance over time. A single user may aggregate data from several wards or institutions for metrics reporting. However, each user cannot access other users' data.
To protect patient privacy, the Web site gives directions on how to anonymize medical record numbers in data files. When registering at the site and requesting access to the application, users are reminded via e-mail that they must anonymize all data prior to upload. They are also instructed to use a code name for all institutions. The site uses Secure Sockets Layer, a cryptographic protocol for secure communications, when communicating login information or any glucose data. This project was approved by the Yale Human Investigations Committee.
Although institutions remain anonymous, the system asks several questions when a user creates an institution or ward. The questions for institutions are as follows:
Is it a member of the Council of Teaching Hospitals specified at the Association of American Medical Colleges Web site?
Is it non-profit?
Is it part of the Veterans Health Administration system?
Is it a public hospital, that is, owned by the city, county, state, or federal government?
Is it located in a rural health area as defined by the University of Washington School of Medicine Rural Health Research Center? (A link to a definition map is given.)
What is its bedsize: <100, 100-400, or >400?
In which of 10 U.S. regions (as designated by the Centers for Medicare & Medicaid Services) is the institution located? Non-U.S. institutions are asked for country of origin.
For specific wards, the following questions are asked:
Is the unit an intensive care unit, and if so, what type: medical, surgical, mixed, cardiothoracic, coronary care, neurosurgical, neurological, neonatal, pediatric, or burn unit? Otherwise, is it a step-down unit or a general ward?
What is the unit's specialty: internal medicine, surgery, medical oncology (and so on)?
Finally, what is the age group of the unit's patients: adult, adolescent, pediatric, or neonatal?
The Web site administrators can use these institutional and ward characteristics to generate anonymous, aggregate glucometrics from the combined data of several institutions. This allows for rough comparisons of glycemic management, for example, between small and large hospitals, between U.S. regions, between medical and surgical units, or between intensive care units and regular wards. Biases inherent within such analyses (e.g., the nature of institutions that utilize such a Web site) will need to be recognized explicitly.
The Web site also provides a detailed description of glucometrics definitions, a forum where users may discuss the metrics and suggest refinements, and a place to share ideas for quality improvement of glycemic management. (Table 2) . Almost all registered users were from the United States, except for 2 from Australia and 1 from Spain. Twenty-five of these users obtained permission to upload data ( Table 3) . Tables 1-3 show users' institutional affiliations and roles. As of December 2007, users had uploaded more than 160 glucose files for glucometrics reports. Figure 2 (a-c) presents a sample glucometrics report for one month, from an adult medical intensive care unit. The report first displays the distribution of bedside glucose values using a composite graphic: a range bar showing data percentiles lying over a histogram (Figure 2a) . This graphic is shown for each of the three units of analysis: patient-stays, patient-days, and patient-samples. Next, a table displays all of the metrics in full detail. This includes the percentage of glucose values that fell within the target range, as well as the percentages of glucose values fulfilling criteria for the adverse events of hypoglycemia and marked hyperglycemia. Figure 2a shows a data file with 1405 samples from 64 patients; there were 374 patient-days. The median glucose measurement for all patient-samples was 146 mg/dl. For patient-stays and patient-days, statistics were computed on the mean glucose measurements of the stay or the day. The number of patient-day mean glucose levels within the target range was 199 (53.2%). The number of patientday means in the hypoglycemic range was 14 (3.7%). The number of patient-day means in the markedly hyperglycemic range was 26 (7.0%).
Figure 2b
shows patients with just a single glucose measurement. Although these values have been excluded from the glucometrics analysis, a histogram shows the distribution of these single values. These measures may be useful for quality improvement. For example, if many of these values are over 200 mg/dl, one may ask why no one performed additional glucose measurements on these patients.
Lastly, three sets of histograms and tables show the frequency of bedside glucose measurements, as well as the total duration of monitoring, in Figure 2c . This information may be helpful in making comparisons between patient care units. For example, a large difference in sampling frequency between units may undermine the validity of comparisons.
The Web site's database stores all uploaded data files and their glucometrics reports. Users may download reports for local sharing or printing, or they may access them later for comparisons to their most recently computed metrics. In addition, users may aggregate several of their data files and generate a composite metrics report over time.
As the Web site administrators, we can aggregate data files from many separate institutions to compute overall glucometrics. We can use these summary results to develop baseline performance benchmarks.
Discussion
National agencies studying quality of care, including the U.S. Joint Commission, have spotlighted optimization of inpatient glycemic control. Defining performance measures and calculating a set of baseline metrics takes the first step toward improving glycemic management across health systems. Presenting these results to frontline clinical staff then provides feedback, which is important to change behavior. This Web service aids institutions in both measuring and reporting glucometrics. The growing response from hospitals and health systems during the year since the Web site's inception (2006) , despite little marketing, shows the rising interest in managing inpatient hyperglycemia. While most registered users of the site were from the United States, the visit log attests to the subject's international appeal. User affiliations and roles suggest that the most common user will be an active member of a quality improvement team in a multihospital health system. However, it requires purchase and installation of proprietary middleware, with an add-on module for glycemic control. In contrast, our Web site is freely accessible over the Internet. Since the application runs on a server maintained at the Yale Center for Medical Informatics, we do not burden the user with software installation or updating. In addition, the other middleware application simply computes its statistics on all blood glucose results, without further analysis by patient-stay or by calendar day. As mentioned previously, this presents problems in the calculation of adverse event rates, which vary widely depending on the unit of analysis. Our Web site offers analysis of glycemic control over three different time units: the patient-stay, the patient-day, and the patient-sample. Such flexibility is valuable to users with various analytic needs.
7 Finally, our Web site also analyzes the frequency and duration of bedside blood glucose sampling on patients in a cohort. This is important in assessing the validity of a data set.
After having collected glucose data from several institutions, we will aggregate data files and compute initial performance benchmarks. These benchmarks should be helpful to institutions wishing to compare their glycemic management to others. Of course, questions will surely arise about the validity of such benchmarks. One concern is lack of data about the prevalence of diabetic patients in patient care units; wide variation in the prevalence of diabetes may produce differences in glucometrics that have nothing to do with diligence in glucose management. Another problem in comparing different types of units, say medical and surgical patient care units, is a mixed patient population; some strictly "medical" patients may reside in a "surgical" unit due to logistical issues. Other questions may arise about associating institutional characteristics with glucometrics performance. For example, public hospitals may treat patients who, for a variety of reasons, have hyperglycemia that is difficult to control. While we have made an effort to characterize the institutions and patient care units uploading data to our server, the addition of other factors relevant to glycemic management will likely be necessary to draw more accurate comparisons.
Our Web site also encourages feedback from users by providing forums for discussion about glucometrics definitions and other material on the site. One pertinent topic is the choice of glucose ranges used in calculating targets and adverse event rates. While the current site does not allow users to modify these ranges, this dynamic feature can be added if the demand arises. In addition, users may share quality improvement strategies that have been successfully implemented at their institutions. Others can then study the effect of such interventions by comparing pre-and postintervention glucometrics within their own organization. By facilitating such interaction, the Web site should help to close the loop from research to clinical application to further research.
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